ENTITY
Pacific Edge

Pacific Edge (PEB NZ)

67
Analysis
Health Care • New Zealand
Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. The Company has completed successful trials in bladder cancer detection and colorectal cancer prognosis.
more
bullish•Pacific Edge
•22 May 2024 06:39•Broker

Pacific Edge - FY24 Result — Stuck in Neutral

NEUTRAL rating given the LCD outcome is binary and therefore high-risk, lab throughput is subdued, and under any scenario the risk of an equity...

Logo
357 Views
Share
bullish•Pacific Edge
•10 Apr 2024 07:02•Broker

Pacific Edge - 4Q24 — Battening Down the Hatches

Pacific Edge's (PEB) 4Q24 update all but confirmed the halt in momentum, with lab throughput down -19% versus 4Q23 and broadly flat versus 3Q24

Logo
443 Views
Share
bullish•Pacific Edge
•23 Jan 2024 07:05•Broker

Pacific Edge - 3Q24 — Cost and Revenue Decline

Pacific Edge's (PEB) 3Q24 update highlights ongoing softness in lab throughput with -8% year on year and -16% sequential declines as it reduces its...

Logo
351 Views
Share
bearish•Pacific Edge
•29 Dec 2023 07:59•Broker

Pacific Edge - Rubber Approaching the Road

Pacific Edge’s (PEB) 2Q24 test volumes highlighted slowing momentum with +8% year on year growth and a -12% sequential decline.

Logo
715 Views
Share
bullish•Pacific Edge
•24 Nov 2023 07:35•Broker

Pacific Edge - 1H24 Result — Kaiser Time

While it has undertaken significant cost reductions to right size the business and manage cash flow this was not seen in its 1H24 result, with most...

Logo
533 Views
Share
x